PharmaShots | Incisive News in 3 Shots

Subscribe Now

OncXerna Therapeutics

OncXerna Therapeutics Reports P-II Trial Results of Bavituximab + Pembrolizumab and New Xerna TME Panel Biomarker Data for Advanced Hepatocellular Carcinoma

OncXerna Therapeutics Reports P-II Trial Results of Bavituximab + Pembrolizumab and New Xerna TME Panel Biomarker Data for Advance...

January 24, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us